New AIDS Drug
Almost every day new breakthroughs are being made in the fight against HIV/AIDS. Just over the last few weeks scientists have announced finding a genetic trait that makes some people less susceptible to the illness, a protein that flushes the virus out of hiding and a drug that could mean longer-lasting treatment for those with the disease.
WBHM’s Rosemary Pennington spoke with Dr. Michael Kilby about that last discovery. Kilby is the medical director of UAB’s HIV/AIDS clinic. He says the researchers at Rutgers University, who created the drug, may have found a way to improve treatment for AIDS patients, but it’s unlikely to be the cure some have hoped it would be.
Trump says 8 EU countries to be charged 10% tariff for opposing US control of Greenland
In a post on social media, Trump said a 10% tariff will take effect on Feb. 1, and will climb to 25% on June 1 if a deal is not in place for the United States to purchase Greenland.
‘Not for sale’: massive protest in Copenhagen against Trump’s desire to acquire Greenland
Thousands of people rallied in Copenhagen to push back on President Trump's rhetoric that the U.S. should acquire Greenland.
Uganda’s longtime leader declared winner in disputed vote
Museveni claims victory in Uganda's contested election as opposition leader Bobi Wine goes into hiding amid chaos, violence and accusations of fraud.
Opinion: Remembering Ai, a remarkably intelligent chimpanzee
We remember Ai, a highly intelligent chimpanzee who lived at the Primate Research Institute of Kyoto University for most of her life, except the time she escaped and walked around campus.
The near death — and last-minute reprieve — of a trial for an HIV vaccine
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would be over before it started.
Is RFK Jr.’s Administration for a Healthy America — AHA — in the works or not?
The Administration for a Healthy America is RFK Jr.'s plan to tackle chronic disease, addiction and other persistent problems. But so far it's not being set up like previous new agencies.
